Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Renhong Tang, PhD
Preclinical Development
Jiangsu Simcere Biological Pharmaceutical Co Ltd, China (People's Republic)
Poster(s):
118: Assessment of Anti-Drug Antibody Incidence in Subcutaneously Administered Antibody-Based Therapeutics Approved Between 2010-2022
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT